Taku Nakashima

ResearcherID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Venues

BMJ open respiratory research

Stem cell research & therapy

Beilstein journal of organic chemistry

The Journal of pathology

Hiroshima University

Hiroshima University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hiroshima University Jul 01 2012

Japan

Assistant professor :: Dept. of Molecular and Internal Medicine

University of Michigan Apr 01 2010 - Jun 30 2012

United States

Postdoctoral fellow :: Pathology

Education History

Hiroshima University Apr 01 2003 - May 31 2008

Japan

PHD

Publications

Shinichiro Miura, Hiroshi Iwamoto, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis. BMJ open respiratory research 11 (1) (2024)
Shinichiro Miura, Hiroshi Iwamoto, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis. BMJ open respiratory research 11 (1) (2024)
Shugo Inada, Taku Nakashima, Takeshi Masuda, Kiyofumi Shimoji, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Yasushi Horimasu, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Sex-related differences in efficacy of bone marrow-derived high aldehyde dehydrogenase activity cells against pulmonary fibrosis. Stem cell research & therapy 15 (1) (2024)
Shinichiro Miura, Hiroshi Iwamoto, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis. BMJ open respiratory research 11 (1) (2024)
Shinichiro Miura, Hiroshi Iwamoto, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis. BMJ open respiratory research 11 (1) (2024)
Kiyofumi Shimoji, Taku Nakashima, Takeshi Masuda, Masashi Namba, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Yasushi Horimasu, Takahiro Mimae, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Morihito Okada, Noboru Hattori
Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression. Journal of translational medicine 21 (1) (2023)
Takashi Oda, Hiroshi Iwamoto, Sachio Takeno, Tomohiro Kawasumi, Kota Takemoto, Manabu Nishida, Nobuyuki Chikuie, Yuichiro Horibe, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Naoko Higaki, Takayuki Taruya, Yasushi Horimasu, Takeshi Masuda, Takao Hamamoto, Taku Nakashima, Takashi Ishino, Tsutomu Ueda, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis. Medicina (Kaunas, Lithuania) 59 (10) (2023)
Takahiro Yamada, Taku Nakashima, Takeshi Masuda, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Nobuhiko Kamada, Noboru Hattori
Intestinal overgrowth of Candida albicans exacerbates bleomycin-induced pulmonary fibrosis in mice with dysbiosis. The Journal of pathology (2023)
Yu Nakanishi, Hiroshi Iwamoto, Shintaro Miyamoto, Satoshi Nakao, Naoko Higaki, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Naoko Matsumoto, Taku Nakashima, Yojiro Onari, Kazunori Fujitaka, Yoshinori Haruta, Hironobu Hamada, Soichiro Hozawa, Noboru Hattori
Association Between Patient Preference for Inhaler Medications and Asthma Outcomes. Journal of asthma and allergy 15 (2022)
Hiroki Tanahashi, Kakuhiro Yamaguchi, Koji Kurose, Satoshi Nakao, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Toru Oga, Mikio Oka, Noboru Hattori
Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis. Respirology (Carlton, Vic.) (2022)
Hiroshi Takahashi, Taku Nakashima, Takeshi Masuda, Masashi Namba, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity. Stem cell research & therapy 12 (1) (2021)
Shun Takao, Taku Nakashima, Takeshi Masuda, Masashi Namba, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Shinya Takahashi, Ayumu Nakashima, Noboru Hattori
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis. Stem cell research & therapy 12 (1) (2021)
Ayato Yamada, Manabu Abe, Yoshinobu Nishimura, Shoji Ishizaka, Masashi Namba, Taku Nakashima, Kiyofumi Shimoji, Noboru Hattori
Photochemical generation of the 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) radical from caged nitroxides by near-infrared two-photon irradiation and its cytocidal effect on lung cancer cells. Beilstein journal of organic chemistry 15 (2019)
Lin Ding, Tianju Liu, Zhe Wu, Biao Hu, Taku Nakashima, Matthew Ullenbruch, Francina Gonzalez De Los Santos, Sem H Phan
Bone Marrow CD11c+ Cell-Derived Amphiregulin Promotes Pulmonary Fibrosis. Journal of immunology (Baltimore, Md. : 1950) 197 (1) (2016)

Taku Nakashima.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Taku Nakashima